Dallas, TX (PRWEB) August 17, 2013
The next generation sequencing market is rapidly evolving with a large number of developments taking place to increase accuracy and speed, and reduce costs of sequencing. It is the fastest-growing and most lucrative segment in the genomics space with an estimated growth of 16.3%. The global NGS market was valued at $1.3 billion in 2012 and is poised to reach $2.7 billion by 2017. By supporting genomics research, various government bodies like NHGRI (National Human Genome Research Institute, U.S.) and Biotechnology and Biological Sciences Research Council (BBSRC, U.K.) are increasing the adoption of high-throughput sequencing platforms.
The growth of the overall NGS market (http://www.reportsnreports.com/reports/257153-next-generation-sequencing-ngs-market-platforms-illumina-hiseq-miseq-life-technologies-ion-proton-pgm-454-roche-bioinformatics-rna-seq-chip-seq-pyrosequencing-sbs-smrt-diagnostics-personalized-medicine-global-forecast-to-2017.html) is driven by continuous innovations and developments in the market aimed at higher throughput, increased accuracy, and affordable costs. However, factors such as high reliability on grants and funding from the government, and decrease in capital expenditure from academic institutions are hindering the growth of the market. In addition, the interpretation of big data generated by sequencers and the subsequent storage and management of the analyzed data is still a challenge. Owing to the complexity of NGS technologies and data, standardization of the overall NGS workflow presents an unmet need. The opportunities for the growth of this market include developments in the pre-sequencing, cloud computing, and NGS bioinformatics solutions.
The NGS platforms market was dominated by Illumina in 2012, which accounted for the largest market share of 56%. Other companies with commercial platforms include Life Technologies (U.S.), 454 Roche (U.S.), and Pacific Biosciences (U.S.). The recently introduced Bench-top and NGS platforms will drive the market. Based on the steps in the NGS workflow, the overall NGS market has three major segments, namely, pre-sequencing, NGS platforms and services, and NGS data analysis, storage and management.
The raw sequencing data generated by today’s sequencers does not reflect on any meaningful information in itself. Also, open source tools for analyzing NGS data require adequate bioinformatics training. These factors open up huge opportunities for commercial NGS bioinformatics software, workbenches, and services, whose market is currently fragmented and has a relatively smaller size. Whole genome sequencing, targeted re-sequencing, de novo sequencing, RNA-Seq, ChIP-Seq and methyl-Seq are the major applications that use NGS data analysis tools and services. Key players like CLC bio (Denmark), Biomatters (New Zealand), Partek (U.S.), Genomatix (Germany), Knome (U.S.), and DNASTAR (U.S.) dominate this market space.
Next generation sequencing is set to revolutionize applied markets like diagnostics, drug discovery, biomarker discovery, personalized medicine, agriculture and animal research. Research institutes and government bodies contribute the highest to the end-user market of NGS; however, the adoption rate in hospitals will increase in the near future due to cost effectiveness, high throughput, and sensitivity.The NGS market will witness a whole new generation of sequencing platforms based on nanapore sequencing technology and fully integrated instruments that could perform all the NGS workflow steps.
Global DNA Sequencing Products Market 2012-2016 covers the Americas, and the EMEA and APAC regions; it also covers the market landscape and its growth prospects in the coming years. The study forecast the Global DNA Sequencing Products market to grow at a CAGR of 18.48% over the period 2012-2016. One of the key factors contributing to this market growth is the introduction of whole genome sequencing. The Global DNA Sequencing Products market has also witnessed an increase in the number of DNA sequencing projects. However, the low adoption of genomic technology could pose a challenge to the growth of this market. The Global DNA Sequencing Products Market (http://www.reportsnreports.com/reports/215315-global-dna-sequencing-products-market-2012-2016.html), has been prepared based on an in-depth analysis of the market with inputs from industry experts.
The key vendors dominating this market space are Agilent Technologies Inc., Hoffmann-La Roche Ltd., Illumina Inc., and Pacific Biosciences of California Inc.The other vendors mentioned in the report are Genia Corp., International Business Machines Corp., Knome Inc., Life Technologies Corp., Oxford Nanopore Technologies Ltd., and RainDance Technologies Inc.
Key questions answered in this report:
Place a direct purchase order for Global DNA Sequencing Products Market 2012-2016 at http://www.reportsnreports.com/Purchase.aspx?name=215315. Alternatively, inquire for discount offered on this report at http://www.reportsnreports.com/contacts/Discount.aspx?name=215315.
Explore more reports related to the Next Generation and DNA Sequencing:
Next Generation Sequencing: Opportunities, Trends and World Market at http://www.reportsnreports.com/reports/103453-next-generation-sequencing-opportunities-trends-and-world-marke.html.
DNA Sequencing 2013: Market Developments, Growth Areas and Opportunities at http://www.reportsnreports.com/reports/253287-dna-sequencing-2013-market-developments-growth-areas-and-opportunities.htm.
Global DNA Sequencing Products Market 2012-2016 at http://www.reportsnreports.com/reports/215315-global-dna-sequencing-products-market-2012-2016.html.
ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. We provide 24/7 online and offline support service to our customers.